epitope between amino acid residues 32 and 79. Hence, p53 protein over expression as detected immunohistochemically indicates a mutation in the p53 domain of missense type or stabilization of the wild type by either cellular or viral products or the presence of DNA damage by a physical or chemical agent. 67 Furthermore, from the work of Caveneee, White and Volgelstein on colon, and brain tumors, 8 ' 9 it is widely believed that cancer development will involve mutations and overexpression of several genes. It is not surprising that recent emphasis to study several oncogene expressions that effect the cell at several subcellular levels is becoming more popular. 10 " With these facts in hand, we were not surprised by our finding that several cellular products and oncogene over expressions can serve as auxiliary tools in diagnostic cytopathology and surgical pathology as well. However, it should not at any time substitute morphologic discipline, as message that we hope did not escape our readers.
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Ethylenediamine Tetraacetic Acidassociated Leukoagglutination
To the Editor-We read with great interest the recent report of Deol and colleagues describing EDTA-associated leukoagglutination. 1 We recently had two patients whose peripheral blood smears showed clumping of leukocytes. The first patient was a 38-year-old black male with alcoholic cirrhosis who subsequently died of liver failure. The CBC results were as follows: WBC 10,200AiL; promyelocytes 1%; myelocytes 1%; metamyelocytes 5%; bands 35%; segmented neutrophils 13%; lymphocytes 33%; monocytes 8%; eosinophils 4%; RBC 2.92 million/ML; HGB 10.2 g/dL; HCT 33%; MCV 113.1 fL; MCH 34.9 pg, MCHC 30.8%, RDW 16%; and nucleated red blood cells 2/100 WBC. His peripheral smear showed clumping of granulocytes in which bands and segmented neutrophils surrounded more immature granulocytes and/or monocytes. The second patient was a 24-year-old female with toxic shock syndrome whose peripheral smear showed clumping of bands and segmented neutrophils. Her CBC revealed: WBC 22,400/ML; myelocytes 3%; bands 53%; segmented neutro-phils 36%; lymphocytes 5%; monocytes 1%; eosinophils 2%; RBC 2.65 million/ nU HGB 8 g/dL; HCT 22.4%; MCV 84.6 fL; MCH 30.1 pg; MCHC 35.5%; RDW 15%; and nucleated red blood cells 5/100 WBC. In both patients, the leukoagglutination was transient and self-limiting. No apparent cause was found for the leukoagglutination.
Clumping of leukocytes in the peripheral blood had been described previously in several case reports. Neoplastic lymphocyte clumping was reported in a patient with chronic lymphocytic leukemia by Bizzaro and colleagues 2 in 1991 and in splenic lymphoma with circulating villous lymphocytes by Juneja and coworkers in 1992 3 and Imbing and associates 4 in 1995. As pointed out by Deol and colleagues, this phenomenon of leukocyte clumping does not only occur in malignant lymphocytes but with benign lymphocytes as well.
EDTA is not the only anticoagulant that causes leukoagglutination. The phenomenon has also been reported with other anticoagulants such as heparin 5 and citrate. 6 It may also occur with more than one anticoagulant in the same patient. 56 Some investigators have reported that the abnormality is corrected by dilution of the patient serum, but in others, dilution of the serum may worsen the phenomenon. 67 An IgM autoantibody has been postulated as the probable cause of this in vitro event but in most of the reported cases, the presence of IgM could not be demonstrated. 7 ' 8 In some cases, platelets are agglutinated whereas in others, only erythrocytes, lymphocytes, and/or granulocytes are affected. The only thing that appears to be common to all the reported cases is the association of the event with room temperature.
Therefore, we conclude that EDTAinduced leukoagglutination is a phenomenon caused by more than one cold agglutinin. Its importance lies in its potential to cause spurious blood count results, thereby causing unnecessary panics and expenses to both physicians and patients. More studies are needed to identify and characterize the culprit autoantibodies.
